Reason for request

Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.


Clinical Benefit


The actual benefit of ADENUIRC is substantial.

Clinical Added Value


The Transparency Committee considers that ADENURIC provides a minor improvement in actual benefit (level IV) in the management of symptomatic chronic hyperuricaemia compared to the current therapeutic strategy based on allopurinol.

Contact Us

Évaluation des médicaments

See also